Trials / Active Not Recruiting
Active Not RecruitingNCT06350734
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 204 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effect of bladder cancer treatment on quality of life.
Detailed description
PRIMARY OBJECTIVES: I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively. II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer. OUTLINE: This is an observational study. Patients complete surveys and also have their medical records reviewed on study.
Conditions
- Stage 0a Bladder Cancer AJCC v8
- Stage 0is Bladder Cancer AJCC v8
- Stage I Bladder Cancer AJCC v8
- Stage II Bladder Cancer AJCC v8
- Stage IIIA Bladder Cancer AJCC v8
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-Interventional Study |
Timeline
- Start date
- 2018-10-12
- Primary completion
- 2029-01-31
- Completion
- 2029-01-31
- First posted
- 2024-04-05
- Last updated
- 2026-04-17
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06350734. Inclusion in this directory is not an endorsement.